Quest Diagnostics (DGX) is scheduled to report Q2 earnings on July 21, 2026. Analysts estimate EPS of $2.82 and quarterly revenue of $2.97B.
In the most recent quarter (Q1), Quest Diagnostics reported EPS of $2.50, beating estimates of $2.36 by 0.06%. Revenue came in at $2.90B, exceeding the estimate of $2.82B by 0.03%.
Quest Diagnostics has beaten EPS estimates in 8 consecutive quarters.
Over the last 4 quarters, Quest Diagnostics has averaged an EPS surprise of 0.04% and a revenue surprise of 0.02%.
Analyze the earnings history of Quest Diagnostics using advanced sorting and filters.
The chart below shows Quest Diagnostics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Quest Diagnostics's reported revenue compared to analyst estimates over recent quarters.
Quest Diagnostics (DGX) is scheduled to report earnings on July 21, 2026. The last reported earnings were for reported on April 21, 2026 for Q1.
The Actual EPS was $2.50, which beat the estimate of $2.36.
The Actual Revenue was $2.90B, which beat the estimate of $2.82B.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-21 | $2.50 | $2.36 | 5.93 % |
| Q4 | 2026-02-10 | $2.42 | $2.35 | 2.98 % |
| Q3 | 2025-10-21 | $2.60 | $2.51 | 3.59 % |
| Q2 | 2025-07-22 | $2.62 | $2.57 | 1.95 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-04-21 | $2.90B | $2.82B | 2.63 % |
| Q4 | 2026-02-10 | $2.81B | $2.76B | 1.76 % |
| Q3 | 2025-10-21 | $2.82B | $2.73B | 3.19 % |
| Q2 | 2025-07-22 | $2.76B | $2.72B | 1.36 % |